Pulmonary embolism: what we need to know

Hot topics
Chairs: D. Jiménez Castro (Madrid, Spain), M. Delcroix (Leuven, Belgium)
Aims: At the end of the session, attendees will be able to: (i) risk stratify patients with acute symptomatic pulmonary embolism (PE); (ii) identify patients with low-risk PE who might benefit from outpatient therapy; (iii) choose the right direct oral anticoagulant for the right patient with acute symptomatic PE; and (iv) identify patients with intermediate-risk PE who might benefit from early recanalisation procedures.

Helping the pulmonary embolism response team (PERT) determine the severity of PE in triage: guidelines O. Sanchez (Paris, France)
Initial outpatient management of PE: who and how? L. Howard (London, United Kingdom)
Update on novel anticoagulants: indications, dosing alternatives and outcomes C. Becattini (Perugia (PG), Italy)
Advanced therapies for life-threatening PE: low-dose systemic thrombolysis, catheter-directed thrombolysis and extracorporeal membrane oxygenation (ECMO) M. Lankeit (Mainz, Germany)